Supplements News and Research

RSS

Common foods linked to arterial stiffening in new metabolomics study

Researchers have identified several lifestyle factors that could cause arteries to stiffen and increase the risk of heart disease, two of which were peptides found in common foods.

7 May 2019

Transplanting gut bacteria from stress-vulnerable rats alters behavior, brain inflammation in recipient

Scientists have shown that transplanting gut bacteria, from an animal that is vulnerable to social stress to a non-stressed animal, can cause vulnerable behavior in the recipient.

7 May 2019

Study pinpoints lifestyle factors that contribute to arterial stiffness

A new study from the University of Georgia pinpoints lifestyle factors that could lead to hardened arteries.

6 May 2019

Protein supplements containing BCAA may have ‘detrimental effects’ on health and lifespan

New research suggests that BCAAs in the form of pre-mixed protein powders, shakes and supplements may do more harm to health than good.

1 May 2019

Disconnect between perceptions of HCPs and people with obesity revealed

The disconnect between perceptions of health care providers and people with obesity is revealed in a new international study presented at this year's European Congress on Obesity in Glasgow, UK, and published in the journal Diabetes, Obesity and Metabolism.

29 Apr 2019

Women who have undergone bariatric surgery may be at higher risk of pregnancy complications

Women who have undergone weight-loss surgery appear to be at higher risk of developing complications during pregnancy, and their babies seem more likely to be born prematurely, small for gestational age, have congenital anomalies and be admitted to intensive care, according to the most comprehensive assessment of how bariatric surgery affects pregnancy outcomes, being presented at this year's European Congress on Obesity in Glasgow, UK (28 April-1 May).

28 Apr 2019

New study aims to determine underlying etiology of seizures and reduce morbidities in children

A new study aims to determine the underlying etiology of seizures and help to target therapy, improve control of seizures, and potentially reduce morbidities in children.

27 Apr 2019

FDA approves perfusion device to help increase access to more donor lungs for transplant

The U.S. Food and Drug Administration today approved a device, called Xvivo Perfusion System with Steen Solution Perfusate, that can temporarily ventilate, oxygenate, and pump (perfuse) preservation solution through lungs that were initially thought to be unacceptable for transplant.

27 Apr 2019

FDA approves new treatment for children with lupus

The U.S. Food and Drug Administration today approved Benlysta (belimumab) intravenous infusion for treatment of children with systemic lupus erythematosus – often referred to as simply "lupus" – a serious chronic disease that causes inflammation and damage to various body tissues and organs.

27 Apr 2019

Scientists develop maps of two melatonin receptors vital for sleep, other biological processes

An international team of researchers used an X-ray laser at the Department of Energy’s SLAC National Accelerator Laboratory to create the first detailed maps of two melatonin receptors that tell our bodies when to go to sleep or wake up and guide other biological processes.

26 Apr 2019

New blood-cell analysis device helps better understand causes and mechanics of rare anemia

An EU-funded project has developed a blood-cell analysis device that helps doctors and scientists better understand the causes and mechanics of rare forms of anemia - potentially speeding up the development of new treatments adjusted to the needs of patients with these diseases.

25 Apr 2019

Factors affecting absorption of ‘sunshine vitamin’ during spring/summer months

Following the hottest Easter Monday on record in the UK, we can easily be lulled into a false sense of security when it comes to our bodies’ vitamin D levels.

24 Apr 2019

FDA grants approval of first generic naloxone nasal spray to treat opioid overdose

The U.S. Food and Drug Administration today granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a life-saving medication that can stop or reverse the effects of an opioid overdose.

22 Apr 2019

FDA authorizes marketing of first medical device to treat ADHD

The U.S. Food and Drug Administration today permitted marketing of the first medical device to treat attention deficit hyperactivity disorder.

22 Apr 2019

FDA orders surgical mesh manufacturers to stop selling and distributing their products in the U.S.

The U.S. Food and Drug Administration today ordered the manufacturers of all remaining surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse (POP) to stop selling and distributing their products in the U.S. immediately.

17 Apr 2019

Keto diet - for the military, aging and epilepsy

Ketogenic diet or keto diet has been in the news as a trending diet option for weight watchers and those who wish to lose those extra pounds.

17 Apr 2019

Researchers identify cause of inherited metabolic disorder

A new study from BC Children's Hospital, the University of British Columbia (UBC) and an international team of researchers published in the New England Journal of Medicine is the first to identify a rarely-seen type of DNA mutation as the cause of an inherited metabolic disorder.

16 Apr 2019

FDA approves new treatment for adults with metastatic bladder cancer

The U.S. Food and Drug Administration today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration known as FGFR3 or FGFR2, and that has progressed during or following prior platinum-containing chemotherapy.

12 Apr 2019

Study estimates how many cancer patients and survivors use complementary, alternative medicines

This study used data from a nationwide survey to estimate how many patients with cancer and cancer survivors use complementary and alternative medicines in addition to or instead of conventional therapies, and how many don't disclose that to their physicians.

12 Apr 2019

One-third of people with cancer use complementary and alternative medicines

A stunning one-third of people with a cancer diagnosis use complementary and alternative medicines such as meditation, yoga, acupuncture, herbal medicine, and supplements.

12 Apr 2019

Supplements News and Research

Common foods linked to arterial stiffening in new metabolomics study

Transplanting gut bacteria from stress-vulnerable rats alters behavior, brain inflammation in recipient

Study pinpoints lifestyle factors that contribute to arterial stiffness

Protein supplements containing BCAA may have ‘detrimental effects’ on health and lifespan

Disconnect between perceptions of HCPs and people with obesity revealed

Women who have undergone bariatric surgery may be at higher risk of pregnancy complications

New study aims to determine underlying etiology of seizures and reduce morbidities in children

FDA approves perfusion device to help increase access to more donor lungs for transplant

FDA approves new treatment for children with lupus

Scientists develop maps of two melatonin receptors vital for sleep, other biological processes

New blood-cell analysis device helps better understand causes and mechanics of rare anemia

Factors affecting absorption of ‘sunshine vitamin’ during spring/summer months

FDA grants approval of first generic naloxone nasal spray to treat opioid overdose

FDA authorizes marketing of first medical device to treat ADHD

FDA orders surgical mesh manufacturers to stop selling and distributing their products in the U.S.

Keto diet - for the military, aging and epilepsy

Researchers identify cause of inherited metabolic disorder

FDA approves new treatment for adults with metastatic bladder cancer

Study estimates how many cancer patients and survivors use complementary, alternative medicines

One-third of people with cancer use complementary and alternative medicines

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News